School of Medicine


Showing 1-5 of 5 Results

  • Dhriti Nagar

    Dhriti Nagar

    Postdoctoral Scholar, Neonatal and Developmental Medicine

    BioPremature birth is a leading cause of developmental and neuropsychiatric disorders in children. One of the factors causing these defects is lowered levels of available oxygen (hypoxia) in the newborn due to immature lungs. My research focuses on understanding the cellular and molecular mechanisms underlying hypoxia-induced developmental disorders of the nervous system due to preterm birth.

  • Michitaka Nakano

    Michitaka Nakano

    Postdoctoral Scholar, Hematology

    BioI am a MD/PhD postdoctoral fellow and medical oncologist with a long-standing interest in translational cancer research. My long-term goal is to be a lab-based physician-scientist and independent academic researcher, translating basic cancer research, and mentoring next-generation scientists. My thesis work in Japan focused on cancer stem cell equilibrium by uniquely applying organoid culture as a method to elucidate cancer stem cell dynamics, which was awarded in Japanese Cancer Association. Along with the development of the field represented by success in T cell checkpoint, my interest gradually shifted to immune oncology while I examined numerous numbers of cancer patients as a medical oncology fellow. My postdoctoral fellowship at Calvin Kuo Lab in Stanford (2019-present) focuses on tumor immune microenvironment. Kuo lab developed a unique 3D air-liquid interface (ALI) organoid system that cultures tumors while preserving their endogenous infiltrating immune cells (T,B ,NK, Myeloid cells). My postdoctoral work will prove the significance of organoids as a translational tool to discover tumor-immune interaction by novel checkpoint inhibitors for immune cells, which can be broadly applicable to basic cancer biology, precision medicine, therapeutics validation and biomarker discovery.

  • Kerem Nernekli

    Kerem Nernekli

    Postdoctoral Scholar, Radiology

    BioDr. Nernekli has a wide-ranging research background encompassing molecular imaging, surgical neuroanatomy, clinical outcome studies, and machine learning, focusing on medical image reconstruction and multimodal deep learning algorithms for classification and segmentation tasks. Currently, he is focused on investigating novel radiotracer and activatable Gd-based contrast agents to detect senescence in large animal models with PET/MRI. Furthermore, Dr. Nernekli is exploring the potential of ferumoxytol-MRI and two-photon microscopy to correlate theranostic nanoparticles in their natural environment in order to gain a deeper understanding of their interactions with tumor-associated microenvironments.